Global Drugs Glass Packaging Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Packaging
Publisher : MRA | Format : PDF
Global Drugs Glass Packaging Market Insights, Forecast to 2034
Pharmaceutical Glass Packaging has a broad range of containers, including injectable, transfusion, diagnostic and syrup bottles, and offers a choice of glass type (I, II, III) and color (clear or amber).
Global Drugs Glass Packaging market is expected to reach to US$ 4951 million in 2023, with a positive growth of %, compared with US$ 5315 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Drugs Glass Packaging industry is evaluated to reach US$ 6634.8 million in 2029. The CAGR will be 5.0% during 2023 to 2029.
The pharma glass bottle packaging market is driven by several key factors. Firstly, the increasing demand for pharmaceutical products, driven by a growing aging population and the prevalence of chronic diseases, has led to a rise in the need for reliable and safe packaging solutions. Glass bottles offer excellent protection against contamination and maintain the integrity of sensitive pharmaceutical formulations, ensuring product efficacy and shelf life. Secondly, stringent regulations and quality standards enforced by regulatory authorities necessitate the use of high-quality packaging materials, making glass a preferred choice due to its inert and non-reactive nature. However, the market faces challenges, such as the higher production costs of glass bottles compared to plastic alternatives. Additionally, the weight and fragility of glass bottles can increase transportation costs and pose logistical challenges for manufacturers and distributors. Striking a balance between product safety and cost-effectiveness remains a critical challenge for the pharma glass bottle packaging market.
Report Covers
This report presents an overview of global Drugs Glass Packaging market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Drugs Glass Packaging market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Gerresheimer
Schott
Stevanato Group
Shandong PG
SGD
Nipro
Ardagh
Bormioli Pharma
West Pharmaceutical
Sisecam Group
Corning Incorporated
PGP Glass
Zhengchuan Pharmaceutical
Stoelzle Glass
Chengdu Jinggu
Segment by Type
Cartridges
Vials
Ampoules
Others
Injection
Transfusion
Others
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Drugs Glass Packaging plant distribution, commercial date of Drugs Glass Packaging, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Drugs Glass Packaging introduction, etc. Drugs Glass Packaging Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14MRAResearch’s Conclusions of Drugs Glass Packaging
Chapter 15Methodology and Data Sources adopted by MRAResearch
Global Drugs Glass Packaging market is expected to reach to US$ 4951 million in 2023, with a positive growth of %, compared with US$ 5315 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Drugs Glass Packaging industry is evaluated to reach US$ 6634.8 million in 2029. The CAGR will be 5.0% during 2023 to 2029.
The pharma glass bottle packaging market is driven by several key factors. Firstly, the increasing demand for pharmaceutical products, driven by a growing aging population and the prevalence of chronic diseases, has led to a rise in the need for reliable and safe packaging solutions. Glass bottles offer excellent protection against contamination and maintain the integrity of sensitive pharmaceutical formulations, ensuring product efficacy and shelf life. Secondly, stringent regulations and quality standards enforced by regulatory authorities necessitate the use of high-quality packaging materials, making glass a preferred choice due to its inert and non-reactive nature. However, the market faces challenges, such as the higher production costs of glass bottles compared to plastic alternatives. Additionally, the weight and fragility of glass bottles can increase transportation costs and pose logistical challenges for manufacturers and distributors. Striking a balance between product safety and cost-effectiveness remains a critical challenge for the pharma glass bottle packaging market.
Report Covers
This report presents an overview of global Drugs Glass Packaging market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Drugs Glass Packaging market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Gerresheimer
Schott
Stevanato Group
Shandong PG
SGD
Nipro
Ardagh
Bormioli Pharma
West Pharmaceutical
Sisecam Group
Corning Incorporated
PGP Glass
Zhengchuan Pharmaceutical
Stoelzle Glass
Chengdu Jinggu
Segment by Type
Cartridges
Vials
Ampoules
Others
Segment by Application
Injection
Transfusion
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Drugs Glass Packaging plant distribution, commercial date of Drugs Glass Packaging, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Drugs Glass Packaging introduction, etc. Drugs Glass Packaging Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14MRAResearch’s Conclusions of Drugs Glass Packaging
Chapter 15Methodology and Data Sources adopted by MRAResearch